SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-19-177524
Filing Date
2019-06-20
Accepted
2019-06-20 16:25:02
Documents
2
Period of Report
2019-06-18
Items
Item 4.01: Changes in Registrant's Certifying Accountant
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d739804d8k.htm 8-K 27239
2 EX-16.1 d739804dex161.htm EX-16.1 1865
  Complete submission text file 0001193125-19-177524.txt   30535
Mailing Address 12230 EL CAMINO REAL SUITE 300 SAN DIEGO CA 92130
Business Address 12230 EL CAMINO REAL SUITE 300 SAN DIEGO CA 92130 (858) 434-1113
Oncternal Therapeutics, Inc. (Filer) CIK: 0001260990 (see all company filings)

IRS No.: 621715807 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-50549 | Film No.: 19908822
SIC: 2834 Pharmaceutical Preparations
Assistant Director 1